China Suspends Production, Sale of Two Leukemia Drugs

China’s drug watchdog and the Ministry of Health (MOH) have suspended the production and sale of methotrexate and cytarabin hydrochloride, two drugs often used to treat acute leukemia and rheumatoid arthritis, made by Shanghai Hualian Pharmaceutical Co., Ltd.
People’s Daily Online